Organon & Co (OGN)
Debt-to-assets ratio
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | 8,751,000 | 8,646,000 | 8,722,000 | 8,703,000 | 8,905,000 | 8,691,000 | 8,884,000 | 9,085,000 | 9,125,000 | 9,259,000 | 9,309,000 | — |
| Total assets | US$ in thousands | 12,058,000 | 11,012,000 | 10,979,000 | 10,763,000 | 10,955,000 | 10,437,000 | 10,614,000 | 10,597,000 | 10,681,000 | 11,335,000 | 10,908,000 | 9,642,000 |
| Debt-to-assets ratio | 0.73 | 0.79 | 0.79 | 0.81 | 0.81 | 0.83 | 0.84 | 0.86 | 0.85 | 0.82 | 0.85 | 0.00 |
December 31, 2023 calculation
Debt-to-assets ratio = Long-term debt ÷ Total assets
= $8,751,000K ÷ $12,058,000K
= 0.73
The trend of Organon & Co.'s debt-to-assets ratio over the past eight quarters shows a gradual increase, starting at 0.73 in Q4 2022 and peaking at 0.86 in Q1 2022. This indicates that the company has been relying more on debt to finance its assets over time. A higher debt-to-assets ratio suggests that a larger portion of the company's assets is financed through debt, which could potentially indicate higher financial risk and lower solvency. It is important for investors and stakeholders to closely monitor this trend to assess the company's financial health and ability to meet its debt obligations.
Peer comparison
Dec 31, 2023